Lv1
98 积分 2024-05-11 加入
The cholinergic anti-inflammatory pathway in humans: State-of-the-art review and future directions
1个月前
已完结
Pulmonary neuroendocrine cell as a therapeutic strategy in pulmonary hypertension: Great expectations or Bleak House?
2个月前
已关闭
COPD and multimorbidity: recognising and addressing a syndemic occurrence
2个月前
已完结
Breathing barriers: bridging lung health, research, and awareness
2个月前
已完结
Lung innervating neurons in lung homeostatic and diseases
5个月前
已完结
Phenotypes in pulmonary hypertension
8个月前
已完结
Platelet FcγRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction
11个月前
已完结
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity
1年前
已完结
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension
1年前
已完结
Spleen-Heart Cross-Talk Through CD23-Mediated Signal Promotes Cardiac Remodeling
1年前
已完结
皖公网安备34019202002308
